GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve charges that the pharmaceutical giant fraudulently marketed the prescription drugs Paxil, Wellbutrin and Avandia, the U.S. Justice Department has announced.Read More »
Much like 2009, 2010 was a busy year for prescription drug suits.
Tagged with: Accutane Allergan antidepressant Avandia AztraZeneca Botox Botox litigation Department of Justice DOJ epilepsy failure to warn GlaxoSmithKline heart attack hormone replacement therapy hormone replacement therapy litigation Johnson & Johnson Levaquin Neurontin Paxil Pfizer Premarin Prempro Provera Roche Seroquel WyethRead More »
A product liability plaintiff could show that her brother’s suicide was the result of a drug maker’s failure to provide adequate warnings for the anti-depressant he started taking shortly before his death, a U.S. District Court in Indiana has ruled ...Read More »
The “learned intermediary” doctrine applies to preclude liability in a wrongful death suit brought by a woman whose husband committed suicide while taking an anti-depressant manufactured by the defendant, the 11th Circuit has ruled in affirming judgment.Read More »
Lawyers USA recaps the big news and notable moments in personal injury law during 2009 -- from Supreme Court decisions to singing courtroom summations.Read More »